nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCG2—Omeprazole—Barrett's esophagus	0.201	0.355	CbGbCtD
Ponatinib—CYP2C8—Omeprazole—Barrett's esophagus	0.107	0.189	CbGbCtD
Ponatinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0737	0.13	CbGbCtD
Ponatinib—ABCB1—Omeprazole—Barrett's esophagus	0.0725	0.128	CbGbCtD
Ponatinib—CYP2D6—Omeprazole—Barrett's esophagus	0.0683	0.121	CbGbCtD
Ponatinib—CYP3A4—Omeprazole—Barrett's esophagus	0.0434	0.0767	CbGbCtD
Ponatinib—ABCB11—bile—Barrett's esophagus	0.0255	0.228	CbGeAlD
Ponatinib—Pain of skin—Esomeprazole—Barrett's esophagus	0.00922	0.0429	CcSEcCtD
Ponatinib—Pain of skin—Omeprazole—Barrett's esophagus	0.00922	0.0429	CcSEcCtD
Ponatinib—FGFR2—exocrine gland—Barrett's esophagus	0.0082	0.0732	CbGeAlD
Ponatinib—FGFR4—digestive system—Barrett's esophagus	0.00608	0.0542	CbGeAlD
Ponatinib—KIT—exocrine gland—Barrett's esophagus	0.0057	0.0508	CbGeAlD
Ponatinib—FGFR3—epithelium—Barrett's esophagus	0.00545	0.0486	CbGeAlD
Ponatinib—RET—epithelium—Barrett's esophagus	0.00376	0.0335	CbGeAlD
Ponatinib—FGFR2—epithelium—Barrett's esophagus	0.00357	0.0318	CbGeAlD
Ponatinib—FGFR2—smooth muscle tissue—Barrett's esophagus	0.00344	0.0307	CbGeAlD
Ponatinib—TEK—epithelium—Barrett's esophagus	0.00342	0.0305	CbGeAlD
Ponatinib—TEK—smooth muscle tissue—Barrett's esophagus	0.0033	0.0294	CbGeAlD
Ponatinib—SRC—epithelium—Barrett's esophagus	0.00304	0.0271	CbGeAlD
Ponatinib—PDGFRA—smooth muscle tissue—Barrett's esophagus	0.00299	0.0266	CbGeAlD
Ponatinib—SRC—smooth muscle tissue—Barrett's esophagus	0.00293	0.0261	CbGeAlD
Ponatinib—RET—digestive system—Barrett's esophagus	0.00286	0.0255	CbGeAlD
Ponatinib—KDR—epithelium—Barrett's esophagus	0.0028	0.0249	CbGeAlD
Ponatinib—ABCB11—digestive system—Barrett's esophagus	0.00279	0.0249	CbGeAlD
Ponatinib—FGFR2—digestive system—Barrett's esophagus	0.00271	0.0242	CbGeAlD
Ponatinib—KDR—smooth muscle tissue—Barrett's esophagus	0.00269	0.024	CbGeAlD
Ponatinib—Petechiae—Omeprazole—Barrett's esophagus	0.00264	0.0123	CcSEcCtD
Ponatinib—Petechiae—Esomeprazole—Barrett's esophagus	0.00264	0.0123	CcSEcCtD
Ponatinib—KIT—epithelium—Barrett's esophagus	0.00248	0.0221	CbGeAlD
Ponatinib—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00241	0.0112	CcSEcCtD
Ponatinib—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00241	0.0112	CcSEcCtD
Ponatinib—KIT—smooth muscle tissue—Barrett's esophagus	0.00239	0.0213	CbGeAlD
Ponatinib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00237	0.011	CcSEcCtD
Ponatinib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00237	0.011	CcSEcCtD
Ponatinib—PDGFRA—digestive system—Barrett's esophagus	0.00236	0.021	CbGeAlD
Ponatinib—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00234	0.0109	CcSEcCtD
Ponatinib—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00234	0.0109	CcSEcCtD
Ponatinib—SRC—digestive system—Barrett's esophagus	0.00231	0.0206	CbGeAlD
Ponatinib—Creatinine increased—Omeprazole—Barrett's esophagus	0.00228	0.0106	CcSEcCtD
Ponatinib—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00228	0.0106	CcSEcCtD
Ponatinib—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00221	0.0103	CcSEcCtD
Ponatinib—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00221	0.0103	CcSEcCtD
Ponatinib—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00217	0.0101	CcSEcCtD
Ponatinib—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00217	0.0101	CcSEcCtD
Ponatinib—KDR—digestive system—Barrett's esophagus	0.00213	0.019	CbGeAlD
Ponatinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00208	0.0185	CbGeAlD
Ponatinib—Fluid retention—Omeprazole—Barrett's esophagus	0.00206	0.0096	CcSEcCtD
Ponatinib—Fluid retention—Esomeprazole—Barrett's esophagus	0.00206	0.0096	CcSEcCtD
Ponatinib—Dry eye—Esomeprazole—Barrett's esophagus	0.00201	0.00934	CcSEcCtD
Ponatinib—Dry eye—Omeprazole—Barrett's esophagus	0.00201	0.00934	CcSEcCtD
Ponatinib—KIT—digestive system—Barrett's esophagus	0.00189	0.0168	CbGeAlD
Ponatinib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00181	0.00844	CcSEcCtD
Ponatinib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00181	0.00844	CcSEcCtD
Ponatinib—Hot flush—Esomeprazole—Barrett's esophagus	0.00169	0.00785	CcSEcCtD
Ponatinib—Hot flush—Omeprazole—Barrett's esophagus	0.00169	0.00785	CcSEcCtD
Ponatinib—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00167	0.00778	CcSEcCtD
Ponatinib—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00167	0.00778	CcSEcCtD
Ponatinib—ABL1—digestive system—Barrett's esophagus	0.00164	0.0146	CbGeAlD
Ponatinib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00158	0.00737	CcSEcCtD
Ponatinib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00158	0.00737	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00158	0.00734	CcSEcCtD
Ponatinib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00158	0.00734	CcSEcCtD
Ponatinib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00158	0.00734	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00158	0.00734	CcSEcCtD
Ponatinib—Migraine—Esomeprazole—Barrett's esophagus	0.00155	0.00723	CcSEcCtD
Ponatinib—Migraine—Omeprazole—Barrett's esophagus	0.00155	0.00723	CcSEcCtD
Ponatinib—Face oedema—Omeprazole—Barrett's esophagus	0.00152	0.00709	CcSEcCtD
Ponatinib—Face oedema—Esomeprazole—Barrett's esophagus	0.00152	0.00709	CcSEcCtD
Ponatinib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00148	0.00688	CcSEcCtD
Ponatinib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00148	0.00688	CcSEcCtD
Ponatinib—Dry skin—Esomeprazole—Barrett's esophagus	0.00145	0.00673	CcSEcCtD
Ponatinib—Dry skin—Omeprazole—Barrett's esophagus	0.00145	0.00673	CcSEcCtD
Ponatinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00144	0.00668	CcSEcCtD
Ponatinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00144	0.00668	CcSEcCtD
Ponatinib—Breast disorder—Omeprazole—Barrett's esophagus	0.00143	0.00663	CcSEcCtD
Ponatinib—Breast disorder—Esomeprazole—Barrett's esophagus	0.00143	0.00663	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00142	0.00661	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00142	0.00661	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00139	0.00648	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00139	0.00648	CcSEcCtD
Ponatinib—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00137	0.00639	CcSEcCtD
Ponatinib—Abdominal distension—Omeprazole—Barrett's esophagus	0.00137	0.00639	CcSEcCtD
Ponatinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00134	0.00622	CcSEcCtD
Ponatinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00134	0.00622	CcSEcCtD
Ponatinib—Angina pectoris—Omeprazole—Barrett's esophagus	0.00133	0.00618	CcSEcCtD
Ponatinib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00133	0.00618	CcSEcCtD
Ponatinib—Pancytopenia—Omeprazole—Barrett's esophagus	0.00129	0.00603	CcSEcCtD
Ponatinib—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00129	0.00603	CcSEcCtD
Ponatinib—Neutropenia—Omeprazole—Barrett's esophagus	0.00127	0.00593	CcSEcCtD
Ponatinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00127	0.00593	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00127	0.0059	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00127	0.0059	CcSEcCtD
Ponatinib—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00126	0.00584	CcSEcCtD
Ponatinib—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00126	0.00584	CcSEcCtD
Ponatinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00123	0.00574	CcSEcCtD
Ponatinib—Weight decreased—Omeprazole—Barrett's esophagus	0.00123	0.00574	CcSEcCtD
Ponatinib—Infestation—Esomeprazole—Barrett's esophagus	0.00122	0.00566	CcSEcCtD
Ponatinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00122	0.00566	CcSEcCtD
Ponatinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00122	0.00566	CcSEcCtD
Ponatinib—Infestation—Omeprazole—Barrett's esophagus	0.00122	0.00566	CcSEcCtD
Ponatinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.00118	0.00551	CcSEcCtD
Ponatinib—Jaundice—Esomeprazole—Barrett's esophagus	0.00118	0.00551	CcSEcCtD
Ponatinib—Stomatitis—Omeprazole—Barrett's esophagus	0.00118	0.00551	CcSEcCtD
Ponatinib—Jaundice—Omeprazole—Barrett's esophagus	0.00118	0.00551	CcSEcCtD
Ponatinib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00118	0.0055	CcSEcCtD
Ponatinib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00118	0.0055	CcSEcCtD
Ponatinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00115	0.00535	CcSEcCtD
Ponatinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00115	0.00535	CcSEcCtD
Ponatinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.00115	0.00534	CcSEcCtD
Ponatinib—Epistaxis—Omeprazole—Barrett's esophagus	0.00115	0.00534	CcSEcCtD
Ponatinib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00109	0.00505	CcSEcCtD
Ponatinib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00109	0.00505	CcSEcCtD
Ponatinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00107	0.005	CcSEcCtD
Ponatinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00107	0.005	CcSEcCtD
Ponatinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00107	0.00499	CcSEcCtD
Ponatinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00107	0.00499	CcSEcCtD
Ponatinib—Visual impairment—Omeprazole—Barrett's esophagus	0.00105	0.00489	CcSEcCtD
Ponatinib—Visual impairment—Esomeprazole—Barrett's esophagus	0.00105	0.00489	CcSEcCtD
Ponatinib—Eye disorder—Omeprazole—Barrett's esophagus	0.00102	0.00475	CcSEcCtD
Ponatinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00102	0.00475	CcSEcCtD
Ponatinib—Flushing—Omeprazole—Barrett's esophagus	0.00101	0.00471	CcSEcCtD
Ponatinib—Flushing—Esomeprazole—Barrett's esophagus	0.00101	0.00471	CcSEcCtD
Ponatinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000983	0.00458	CcSEcCtD
Ponatinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000983	0.00458	CcSEcCtD
Ponatinib—Chills—Esomeprazole—Barrett's esophagus	0.000979	0.00456	CcSEcCtD
Ponatinib—Chills—Omeprazole—Barrett's esophagus	0.000979	0.00456	CcSEcCtD
Ponatinib—Alopecia—Esomeprazole—Barrett's esophagus	0.000964	0.00449	CcSEcCtD
Ponatinib—Alopecia—Omeprazole—Barrett's esophagus	0.000964	0.00449	CcSEcCtD
Ponatinib—CYP3A5—digestive system—Barrett's esophagus	0.000961	0.00857	CbGeAlD
Ponatinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000956	0.00445	CcSEcCtD
Ponatinib—Mental disorder—Omeprazole—Barrett's esophagus	0.000956	0.00445	CcSEcCtD
Ponatinib—Malnutrition—Omeprazole—Barrett's esophagus	0.00095	0.00442	CcSEcCtD
Ponatinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00095	0.00442	CcSEcCtD
Ponatinib—Back pain—Esomeprazole—Barrett's esophagus	0.000919	0.00428	CcSEcCtD
Ponatinib—Back pain—Omeprazole—Barrett's esophagus	0.000919	0.00428	CcSEcCtD
Ponatinib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000913	0.00425	CcSEcCtD
Ponatinib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000913	0.00425	CcSEcCtD
Ponatinib—Vision blurred—Omeprazole—Barrett's esophagus	0.000895	0.00417	CcSEcCtD
Ponatinib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000895	0.00417	CcSEcCtD
Ponatinib—Anaemia—Esomeprazole—Barrett's esophagus	0.000878	0.00409	CcSEcCtD
Ponatinib—Anaemia—Omeprazole—Barrett's esophagus	0.000878	0.00409	CcSEcCtD
Ponatinib—Leukopenia—Omeprazole—Barrett's esophagus	0.00085	0.00396	CcSEcCtD
Ponatinib—Leukopenia—Esomeprazole—Barrett's esophagus	0.00085	0.00396	CcSEcCtD
Ponatinib—Cough—Esomeprazole—Barrett's esophagus	0.000829	0.00386	CcSEcCtD
Ponatinib—Cough—Omeprazole—Barrett's esophagus	0.000829	0.00386	CcSEcCtD
Ponatinib—Hypertension—Esomeprazole—Barrett's esophagus	0.00082	0.00382	CcSEcCtD
Ponatinib—Hypertension—Omeprazole—Barrett's esophagus	0.00082	0.00382	CcSEcCtD
Ponatinib—Myalgia—Omeprazole—Barrett's esophagus	0.000809	0.00376	CcSEcCtD
Ponatinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000809	0.00376	CcSEcCtD
Ponatinib—Myalgia—Esomeprazole—Barrett's esophagus	0.000809	0.00376	CcSEcCtD
Ponatinib—Arthralgia—Omeprazole—Barrett's esophagus	0.000809	0.00376	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000803	0.00374	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000803	0.00374	CcSEcCtD
Ponatinib—Dry mouth—Esomeprazole—Barrett's esophagus	0.000791	0.00368	CcSEcCtD
Ponatinib—Dry mouth—Omeprazole—Barrett's esophagus	0.000791	0.00368	CcSEcCtD
Ponatinib—Infection—Esomeprazole—Barrett's esophagus	0.00077	0.00358	CcSEcCtD
Ponatinib—Infection—Omeprazole—Barrett's esophagus	0.00077	0.00358	CcSEcCtD
Ponatinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00076	0.00354	CcSEcCtD
Ponatinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00076	0.00354	CcSEcCtD
Ponatinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000759	0.00353	CcSEcCtD
Ponatinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000759	0.00353	CcSEcCtD
Ponatinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000753	0.00351	CcSEcCtD
Ponatinib—Skin disorder—Omeprazole—Barrett's esophagus	0.000753	0.00351	CcSEcCtD
Ponatinib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000749	0.00349	CcSEcCtD
Ponatinib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000749	0.00349	CcSEcCtD
Ponatinib—CYP3A4—digestive system—Barrett's esophagus	0.000721	0.00643	CbGeAlD
Ponatinib—CYP2D6—digestive system—Barrett's esophagus	0.000709	0.00633	CbGeAlD
Ponatinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000706	0.00329	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000706	0.00329	CcSEcCtD
Ponatinib—Insomnia—Esomeprazole—Barrett's esophagus	0.000701	0.00326	CcSEcCtD
Ponatinib—Insomnia—Omeprazole—Barrett's esophagus	0.000701	0.00326	CcSEcCtD
Ponatinib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000696	0.00324	CcSEcCtD
Ponatinib—Paraesthesia—Omeprazole—Barrett's esophagus	0.000696	0.00324	CcSEcCtD
Ponatinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000691	0.00322	CcSEcCtD
Ponatinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000691	0.00322	CcSEcCtD
Ponatinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000682	0.00318	CcSEcCtD
Ponatinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000682	0.00318	CcSEcCtD
Ponatinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000674	0.00314	CcSEcCtD
Ponatinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000674	0.00314	CcSEcCtD
Ponatinib—ABCB1—epithelium—Barrett's esophagus	0.000671	0.00598	CbGeAlD
Ponatinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000669	0.00312	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000669	0.00312	CcSEcCtD
Ponatinib—Fatigue—Esomeprazole—Barrett's esophagus	0.000668	0.00311	CcSEcCtD
Ponatinib—Fatigue—Omeprazole—Barrett's esophagus	0.000668	0.00311	CcSEcCtD
Ponatinib—Pain—Omeprazole—Barrett's esophagus	0.000663	0.00309	CcSEcCtD
Ponatinib—Constipation—Omeprazole—Barrett's esophagus	0.000663	0.00309	CcSEcCtD
Ponatinib—Pain—Esomeprazole—Barrett's esophagus	0.000663	0.00309	CcSEcCtD
Ponatinib—Constipation—Esomeprazole—Barrett's esophagus	0.000663	0.00309	CcSEcCtD
Ponatinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000634	0.00295	CcSEcCtD
Ponatinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000634	0.00295	CcSEcCtD
Ponatinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000613	0.00285	CcSEcCtD
Ponatinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000613	0.00285	CcSEcCtD
Ponatinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000613	0.00285	CcSEcCtD
Ponatinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000613	0.00285	CcSEcCtD
Ponatinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000556	0.00259	CcSEcCtD
Ponatinib—Asthenia—Omeprazole—Barrett's esophagus	0.000556	0.00259	CcSEcCtD
Ponatinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000548	0.00255	CcSEcCtD
Ponatinib—Pruritus—Omeprazole—Barrett's esophagus	0.000548	0.00255	CcSEcCtD
Ponatinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.00053	0.00247	CcSEcCtD
Ponatinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00053	0.00247	CcSEcCtD
Ponatinib—Dizziness—Esomeprazole—Barrett's esophagus	0.000513	0.00239	CcSEcCtD
Ponatinib—Dizziness—Omeprazole—Barrett's esophagus	0.000513	0.00239	CcSEcCtD
Ponatinib—ABCB1—digestive system—Barrett's esophagus	0.00051	0.00455	CbGeAlD
Ponatinib—Vomiting—Omeprazole—Barrett's esophagus	0.000493	0.00229	CcSEcCtD
Ponatinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000493	0.00229	CcSEcCtD
Ponatinib—Rash—Omeprazole—Barrett's esophagus	0.000489	0.00228	CcSEcCtD
Ponatinib—Rash—Esomeprazole—Barrett's esophagus	0.000489	0.00228	CcSEcCtD
Ponatinib—Dermatitis—Omeprazole—Barrett's esophagus	0.000488	0.00227	CcSEcCtD
Ponatinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000488	0.00227	CcSEcCtD
Ponatinib—Headache—Omeprazole—Barrett's esophagus	0.000486	0.00226	CcSEcCtD
Ponatinib—Headache—Esomeprazole—Barrett's esophagus	0.000486	0.00226	CcSEcCtD
Ponatinib—Nausea—Omeprazole—Barrett's esophagus	0.00046	0.00214	CcSEcCtD
Ponatinib—Nausea—Esomeprazole—Barrett's esophagus	0.00046	0.00214	CcSEcCtD
Ponatinib—BCR—Signaling Pathways—SST—Barrett's esophagus	0.000145	0.00136	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000145	0.00135	CbGpPWpGaD
Ponatinib—KIT—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000145	0.00135	CbGpPWpGaD
Ponatinib—ABL1—miRNA Regulation of DNA Damage Response—TP53—Barrett's esophagus	0.000144	0.00135	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000144	0.00135	CbGpPWpGaD
Ponatinib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000144	0.00135	CbGpPWpGaD
Ponatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000143	0.00134	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000143	0.00134	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—HGF—Barrett's esophagus	0.000143	0.00134	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000138	0.00129	CbGpPWpGaD
Ponatinib—FGFR1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000137	0.00128	CbGpPWpGaD
Ponatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000137	0.00128	CbGpPWpGaD
Ponatinib—FGFR2—B Cell Activation—RELA—Barrett's esophagus	0.000136	0.00128	CbGpPWpGaD
Ponatinib—KIT—B Cell Activation—RELA—Barrett's esophagus	0.000134	0.00125	CbGpPWpGaD
Ponatinib—SRC—BDNF signaling pathway—APC—Barrett's esophagus	0.000132	0.00124	CbGpPWpGaD
Ponatinib—SRC—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000131	0.00123	CbGpPWpGaD
Ponatinib—FGFR1—B Cell Activation—RELA—Barrett's esophagus	0.000127	0.00119	CbGpPWpGaD
Ponatinib—PDGFRA—B Cell Activation—RELA—Barrett's esophagus	0.000127	0.00119	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000126	0.00118	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGES—Barrett's esophagus	0.000126	0.00118	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000125	0.00117	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000125	0.00117	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000125	0.00117	CbGpPWpGaD
Ponatinib—ABL1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000123	0.00115	CbGpPWpGaD
Ponatinib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000123	0.00115	CbGpPWpGaD
Ponatinib—FGFR3—Disease—SLC9A1—Barrett's esophagus	0.000121	0.00113	CbGpPWpGaD
Ponatinib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000121	0.00113	CbGpPWpGaD
Ponatinib—LYN—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000121	0.00113	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000118	0.00111	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000116	0.00108	CbGpPWpGaD
Ponatinib—SRC—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000113	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—HGF—Barrett's esophagus	0.000113	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Innate Immune System—RELA—Barrett's esophagus	0.000112	0.00105	CbGpPWpGaD
Ponatinib—LYN—B Cell Activation—RELA—Barrett's esophagus	0.000112	0.00105	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—GAST—Barrett's esophagus	0.000111	0.00103	CbGpPWpGaD
Ponatinib—SRC—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.00011	0.00103	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.00011	0.00103	CbGpPWpGaD
Ponatinib—BCR—Disease—APC—Barrett's esophagus	0.00011	0.00103	CbGpPWpGaD
Ponatinib—ABL1—Cell Cycle—TP53—Barrett's esophagus	0.000108	0.00101	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—RELA—Barrett's esophagus	0.000108	0.00101	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000106	0.000988	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000104	0.000971	CbGpPWpGaD
Ponatinib—SRC—BDNF signaling pathway—RELA—Barrett's esophagus	0.000103	0.000967	CbGpPWpGaD
Ponatinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000102	0.000959	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—SST—Barrett's esophagus	0.000102	0.000959	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—PPARG—Barrett's esophagus	0.000101	0.000949	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by NGF—RELA—Barrett's esophagus	0.0001	0.000939	CbGpPWpGaD
Ponatinib—LCK—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	9.9e-05	0.000927	CbGpPWpGaD
Ponatinib—KIT—Signaling by NGF—RELA—Barrett's esophagus	9.85e-05	0.000922	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.69e-05	0.000907	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—GAST—Barrett's esophagus	9.63e-05	0.000902	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CYP26A1—Barrett's esophagus	9.53e-05	0.000892	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	9.38e-05	0.000878	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by NGF—RELA—Barrett's esophagus	9.35e-05	0.000875	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—RELA—Barrett's esophagus	9.33e-05	0.000873	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	9.31e-05	0.000872	CbGpPWpGaD
Ponatinib—LCK—B Cell Activation—RELA—Barrett's esophagus	9.16e-05	0.000857	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—HGF—Barrett's esophagus	8.98e-05	0.000841	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—HGF—Barrett's esophagus	8.94e-05	0.000837	CbGpPWpGaD
Ponatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	8.58e-05	0.000803	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.55e-05	0.0008	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	8.37e-05	0.000783	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HGF—Barrett's esophagus	8.35e-05	0.000782	CbGpPWpGaD
Ponatinib—BCR—Disease—PTGS2—Barrett's esophagus	8.34e-05	0.000781	CbGpPWpGaD
Ponatinib—FGFR2—Disease—SLC9A1—Barrett's esophagus	8.33e-05	0.000779	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—RELA—Barrett's esophagus	8.32e-05	0.000779	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGES—Barrett's esophagus	8.31e-05	0.000778	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TP53—Barrett's esophagus	8.28e-05	0.000775	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—RELA—Barrett's esophagus	8.21e-05	0.000768	CbGpPWpGaD
Ponatinib—KIT—Disease—SLC9A1—Barrett's esophagus	8.18e-05	0.000765	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.01e-05	0.00075	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—RELA—Barrett's esophagus	7.99e-05	0.000748	CbGpPWpGaD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	7.89e-05	0.000739	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—TP53—Barrett's esophagus	7.77e-05	0.000727	CbGpPWpGaD
Ponatinib—FGFR1—Disease—SLC9A1—Barrett's esophagus	7.76e-05	0.000726	CbGpPWpGaD
Ponatinib—FGFR4—Disease—APC—Barrett's esophagus	7.74e-05	0.000725	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—SLC9A1—Barrett's esophagus	7.74e-05	0.000725	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	7.7e-05	0.00072	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—APC—Barrett's esophagus	7.69e-05	0.00072	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—GAST—Barrett's esophagus	7.6e-05	0.000712	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—SST—Barrett's esophagus	7.58e-05	0.000709	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.47e-05	0.000699	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—GAST—Barrett's esophagus	7.47e-05	0.000699	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—PPARG—Barrett's esophagus	7.46e-05	0.000698	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.45e-05	0.000697	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—HGF—Barrett's esophagus	7.36e-05	0.000689	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—GAST—Barrett's esophagus	7.09e-05	0.000663	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—GAST—Barrett's esophagus	7.07e-05	0.000662	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.04e-05	0.000659	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—SLC9A1—Barrett's esophagus	6.87e-05	0.000643	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	6.86e-05	0.000642	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—RELA—Barrett's esophagus	6.74e-05	0.000631	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SST—Barrett's esophagus	6.6e-05	0.000618	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—PPARG—Barrett's esophagus	6.56e-05	0.000614	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—RELA—Barrett's esophagus	6.55e-05	0.000613	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.54e-05	0.000612	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	6.53e-05	0.000611	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—HGF—Barrett's esophagus	6.52e-05	0.00061	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	6.41e-05	0.0006	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	6.3e-05	0.00059	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.24e-05	0.000584	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—GAST—Barrett's esophagus	6.24e-05	0.000584	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—RELA—Barrett's esophagus	6.04e-05	0.000565	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—RELA—Barrett's esophagus	6.01e-05	0.000563	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—RELA—Barrett's esophagus	5.97e-05	0.000559	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	5.95e-05	0.000557	CbGpPWpGaD
Ponatinib—FGFR4—Disease—PTGS2—Barrett's esophagus	5.88e-05	0.00055	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HGF—Barrett's esophagus	5.74e-05	0.000538	CbGpPWpGaD
Ponatinib—FGFR3—Disease—APC—Barrett's esophagus	5.73e-05	0.000536	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—RELA—Barrett's esophagus	5.72e-05	0.000536	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—CXCL8—Barrett's esophagus	5.66e-05	0.00053	CbGpPWpGaD
Ponatinib—KIT—Immune System—HGF—Barrett's esophagus	5.64e-05	0.000528	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—RELA—Barrett's esophagus	5.62e-05	0.000526	CbGpPWpGaD
Ponatinib—LCK—Disease—SLC9A1—Barrett's esophagus	5.6e-05	0.000524	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.54e-05	0.000518	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—RELA—Barrett's esophagus	5.49e-05	0.000514	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—APC—Barrett's esophagus	5.42e-05	0.000507	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—RELA—Barrett's esophagus	5.4e-05	0.000505	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HGF—Barrett's esophagus	5.35e-05	0.000501	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HGF—Barrett's esophagus	5.34e-05	0.0005	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—RELA—Barrett's esophagus	5.33e-05	0.000499	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—RELA—Barrett's esophagus	5.32e-05	0.000498	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—RELA—Barrett's esophagus	5.31e-05	0.000497	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	5.29e-05	0.000495	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.24e-05	0.000491	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SST—Barrett's esophagus	5.21e-05	0.000488	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	5.16e-05	0.000483	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—RELA—Barrett's esophagus	5.12e-05	0.000479	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SST—Barrett's esophagus	5.12e-05	0.000479	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—GAST—Barrett's esophagus	5.11e-05	0.000478	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—RELA—Barrett's esophagus	5.11e-05	0.000478	CbGpPWpGaD
Ponatinib—SRC—Disease—SLC9A1—Barrett's esophagus	4.95e-05	0.000464	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SST—Barrett's esophagus	4.86e-05	0.000455	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—RELA—Barrett's esophagus	4.85e-05	0.000454	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SST—Barrett's esophagus	4.85e-05	0.000454	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.77e-05	0.000446	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—PPARG—Barrett's esophagus	4.76e-05	0.000446	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.74e-05	0.000444	CbGpPWpGaD
Ponatinib—LYN—Immune System—HGF—Barrett's esophagus	4.71e-05	0.000441	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—RELA—Barrett's esophagus	4.69e-05	0.000439	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HGF—Barrett's esophagus	4.69e-05	0.000439	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	4.67e-05	0.000437	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	4.54e-05	0.000425	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—GAST—Barrett's esophagus	4.52e-05	0.000424	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	4.51e-05	0.000422	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—RELA—Barrett's esophagus	4.51e-05	0.000422	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	4.49e-05	0.000421	CbGpPWpGaD
Ponatinib—FGFR3—Disease—PTGS2—Barrett's esophagus	4.35e-05	0.000407	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SST—Barrett's esophagus	4.27e-05	0.0004	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—RELA—Barrett's esophagus	4.24e-05	0.000396	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	4.23e-05	0.000396	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—APC—Barrett's esophagus	4.01e-05	0.000375	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CXCL8—Barrett's esophagus	3.99e-05	0.000374	CbGpPWpGaD
Ponatinib—FGFR2—Disease—APC—Barrett's esophagus	3.94e-05	0.000369	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	3.91e-05	0.000366	CbGpPWpGaD
Ponatinib—KIT—Disease—APC—Barrett's esophagus	3.87e-05	0.000362	CbGpPWpGaD
Ponatinib—LCK—Immune System—HGF—Barrett's esophagus	3.86e-05	0.000361	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—RELA—Barrett's esophagus	3.86e-05	0.000361	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—RELA—Barrett's esophagus	3.85e-05	0.00036	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	3.69e-05	0.000346	CbGpPWpGaD
Ponatinib—FGFR1—Disease—APC—Barrett's esophagus	3.67e-05	0.000344	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—APC—Barrett's esophagus	3.66e-05	0.000343	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SST—Barrett's esophagus	3.5e-05	0.000328	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—APC—Barrett's esophagus	3.49e-05	0.000327	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TP53—Barrett's esophagus	3.48e-05	0.000325	CbGpPWpGaD
Ponatinib—SRC—Immune System—HGF—Barrett's esophagus	3.42e-05	0.00032	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	3.41e-05	0.000319	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—RELA—Barrett's esophagus	3.4e-05	0.000319	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—RELA—Barrett's esophagus	3.33e-05	0.000312	CbGpPWpGaD
Ponatinib—KIT—Immune System—RELA—Barrett's esophagus	3.27e-05	0.000306	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—RELA—Barrett's esophagus	3.27e-05	0.000306	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	3.25e-05	0.000304	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	3.21e-05	0.0003	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PPARG—Barrett's esophagus	3.14e-05	0.000293	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—RELA—Barrett's esophagus	3.13e-05	0.000293	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—RELA—Barrett's esophagus	3.11e-05	0.000291	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SST—Barrett's esophagus	3.1e-05	0.00029	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—RELA—Barrett's esophagus	3.1e-05	0.00029	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TP53—Barrett's esophagus	3.01e-05	0.000282	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TP53—Barrett's esophagus	3e-05	0.000281	CbGpPWpGaD
Ponatinib—FGFR2—Disease—PTGS2—Barrett's esophagus	2.99e-05	0.00028	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CXCL8—Barrett's esophagus	2.95e-05	0.000276	CbGpPWpGaD
Ponatinib—KIT—Disease—PTGS2—Barrett's esophagus	2.94e-05	0.000275	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.89e-05	0.00027	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.82e-05	0.000264	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	2.82e-05	0.000264	CbGpPWpGaD
Ponatinib—FGFR1—Disease—PTGS2—Barrett's esophagus	2.79e-05	0.000261	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTGS2—Barrett's esophagus	2.78e-05	0.00026	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.77e-05	0.000259	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—APC—Barrett's esophagus	2.76e-05	0.000258	CbGpPWpGaD
Ponatinib—LYN—Immune System—RELA—Barrett's esophagus	2.73e-05	0.000256	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—RELA—Barrett's esophagus	2.73e-05	0.000255	CbGpPWpGaD
Ponatinib—ABL1—Immune System—RELA—Barrett's esophagus	2.72e-05	0.000255	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—APC—Barrett's esophagus	2.71e-05	0.000254	CbGpPWpGaD
Ponatinib—LCK—Disease—APC—Barrett's esophagus	2.65e-05	0.000248	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CXCL8—Barrett's esophagus	2.57e-05	0.000241	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—APC—Barrett's esophagus	2.57e-05	0.000241	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—APC—Barrett's esophagus	2.56e-05	0.00024	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TP53—Barrett's esophagus	2.47e-05	0.000231	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGS2—Barrett's esophagus	2.47e-05	0.000231	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.45e-05	0.00023	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TP53—Barrett's esophagus	2.45e-05	0.000229	CbGpPWpGaD
Ponatinib—SRC—Disease—APC—Barrett's esophagus	2.34e-05	0.000219	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.31e-05	0.000217	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.27e-05	0.000213	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—APC—Barrett's esophagus	2.26e-05	0.000212	CbGpPWpGaD
Ponatinib—LCK—Immune System—RELA—Barrett's esophagus	2.24e-05	0.00021	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TP53—Barrett's esophagus	2.19e-05	0.000205	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—RELA—Barrett's esophagus	2.15e-05	0.000202	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—RELA—Barrett's esophagus	2.12e-05	0.000198	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.1e-05	0.000196	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	2.07e-05	0.000194	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL8—Barrett's esophagus	2.03e-05	0.00019	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—Barrett's esophagus	2.01e-05	0.000188	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RELA—Barrett's esophagus	2.01e-05	0.000188	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RELA—Barrett's esophagus	2e-05	0.000188	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL8—Barrett's esophagus	1.99e-05	0.000187	CbGpPWpGaD
Ponatinib—SRC—Immune System—RELA—Barrett's esophagus	1.98e-05	0.000186	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL8—Barrett's esophagus	1.89e-05	0.000177	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL8—Barrett's esophagus	1.89e-05	0.000177	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—APC—Barrett's esophagus	1.85e-05	0.000173	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TP53—Barrett's esophagus	1.81e-05	0.00017	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—Barrett's esophagus	1.78e-05	0.000167	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RELA—Barrett's esophagus	1.77e-05	0.000165	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL8—Barrett's esophagus	1.67e-05	0.000156	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—APC—Barrett's esophagus	1.64e-05	0.000154	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.63e-05	0.000153	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TP53—Barrett's esophagus	1.58e-05	0.000148	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.51e-05	0.000142	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.48e-05	0.000139	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RELA—Barrett's esophagus	1.45e-05	0.000136	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	1.36e-05	0.000128	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.29e-05	0.00012	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RELA—Barrett's esophagus	1.28e-05	0.00012	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TP53—Barrett's esophagus	1.25e-05	0.000117	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TP53—Barrett's esophagus	1.22e-05	0.000115	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL8—Barrett's esophagus	1.21e-05	0.000113	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.17e-05	0.000109	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TP53—Barrett's esophagus	1.16e-05	0.000109	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TP53—Barrett's esophagus	1.16e-05	0.000108	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.12e-05	0.000105	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.06e-05	9.88e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TP53—Barrett's esophagus	1.02e-05	9.56e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	1.01e-05	9.47e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	8.81e-06	8.25e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TP53—Barrett's esophagus	8.38e-06	7.84e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	8.31e-06	7.78e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TP53—Barrett's esophagus	7.41e-06	6.94e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	6.9e-06	6.46e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	5.43e-06	5.08e-05	CbGpPWpGaD
